CaMKIIbeta: a regulator of CNS myelination
CaMKIIbeta:中枢神经系统髓鞘形成的调节因子
基本信息
- 批准号:8707006
- 负责人:
- 金额:$ 19.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAffectAgreementApplications GrantsAxonBindingCa(2+)-Calmodulin Dependent Protein KinaseCalcium/calmodulin-dependent protein kinaseCell LineageCell MaturationCellsCellular MorphologyComplexCytoskeletonDataDemyelinating DiseasesDemyelinationsDendritic SpinesDevelopmentEquilibriumFamily memberGene ExpressionGoalsGrowth ConesHumanIn VitroKineticsKnock-outKnockout MiceLesionMicrofilamentsMolecularMorphologyMultiple SclerosisMultiple Sclerosis LesionsMutationMyelinMyelin SheathNeuraxisNeuronsOligodendrogliaPatientsPhosphotransferasesPrevalenceProcessPropertyProtein FamilyProtein-Serine-Threonine KinasesPublishingRegulationRoleSignal TransductionTestingTimebasecalmodulin-dependent protein kinase IIgenetic regulatory proteinin vivoinsightmembermyelinationnervous system disorderoligodendrocyte lineagepreventprogenitorpublic health relevanceremyelinationrepairedresearch study
项目摘要
DESCRIPTION (provided by applicant): Maturation of cells of the oligodendrocyte (OLG) lineage is characterized by extensive changes in cellular morphology. These changes are to a large extent driven by changes in the actin cytoskeleton. Interestingly, within lesions seen in the
central nervous system (CNS) of patients suffering from the major human demyelinating disease Multiple Sclerosis, OLG differentiation appears blocked and actin cytoskeleton regulatory mechanisms misregulated. Thus and as an approach toward a better understanding on how to achieve myelin repair under pathological conditions, the long-term goal of the studies proposed in this grant application is to gain insight into the role of actin cytoskeleton regulator mechanisms in the overall control of OLG differentiation and CNS myelination. Our recently published and preliminary studies identified calcium/calmodulin-dependent protein kinase Ii¿ (CaMKII¿) as a good candidate for a factor that can modulate kinetic stability versus dynamic remodeling of the OLG's actin cytoskeleton and thereby regulate OLG maturation and CNS myelination. Based on our data we propose as our central hypothesis that CaMKII¿ acts in differentiating OLGs as an actin cytoskeleton regulatory protein critically involved in controlling
the morphological aspects of OLG maturation and myelination. To address this hypothesis we will complete the following two specific aims: 1) we will characterize in vivo the role of OLGderived CaMKII¿ in regulating developmental myelination and the myelin-associated actin cytoskeleton and 2) we will characterize in vitro the role of CaMKII¿ and its actin binding/ stabilizing domain in regulating the maturation of differentiating OLG and the OLG's actin cytoskeleton. Taken together, the experiments to be completed as part of this grant proposal are anticipated to build the basis for continuing studies in which to further assess the role of th CaMKII¿-actin cytoskeleton axis in CNS myelination as well as remyelination and to thus contribute to a better understanding on how to stimulate CNS repair under pathological demyelinating conditions.
描述(由申请方提供):少突胶质细胞(OLG)谱系细胞的成熟以细胞形态的广泛变化为特征。这些变化在很大程度上是由肌动蛋白细胞骨架的变化驱动的。有趣的是,在病变中,
患有人类主要脱髓鞘疾病多发性硬化症的患者的中枢神经系统(CNS),OLG分化似乎被阻断并且肌动蛋白细胞骨架调节机制失调。因此,作为一种更好地理解如何在病理条件下实现髓鞘修复的方法,本研究的长期目标是深入了解肌动蛋白细胞骨架调节机制在OLG分化和CNS髓鞘形成的整体控制中的作用。我们最近发表的和初步的研究确定钙/钙调蛋白依赖性蛋白激酶Ii <$$>(CaMKII <$)作为一个很好的候选因子,可以调节动力学稳定性与动态重塑的OLG的肌动蛋白细胞骨架,从而调节OLG成熟和中枢神经系统髓鞘形成。基于我们的数据,我们提出了我们的中心假设,即CaMKII作为一种肌动蛋白细胞骨架调节蛋白,在分化OLG中起作用,
OLG成熟和髓鞘形成的形态学方面。为了解决这一假设,我们将完成以下两个具体目标:1)我们将在体内表征OLG衍生的CaMKII?在调节发育髓鞘形成和髓鞘相关肌动蛋白细胞骨架中的作用,2)我们将在体外表征CaMKII?及其肌动蛋白结合/稳定结构域在调节分化OLG和OLG肌动蛋白细胞骨架成熟中的作用。综上所述,作为本拨款提案的一部分,预计将完成的实验将为继续研究奠定基础,进一步评估CaMKII <$-肌动蛋白细胞骨架轴在CNS髓鞘形成和髓鞘再生中的作用,从而有助于更好地了解如何在病理性脱髓鞘条件下刺激CNS修复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BABETTE FUSS其他文献
BABETTE FUSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BABETTE FUSS', 18)}}的其他基金
LPA6 signaling as a modulator of oligodendrocyte differentiation and CNS myelination
LPA6 信号作为少突胶质细胞分化和 CNS 髓鞘形成的调节剂
- 批准号:
10288115 - 财政年份:2021
- 资助金额:
$ 19.06万 - 项目类别:
47th Annual Meeting of the American Society for Neurochemistry
第 47 届美国神经化学学会年会
- 批准号:
9123121 - 财政年份:2016
- 资助金额:
$ 19.06万 - 项目类别:
Glutamate transporters as regulators of CNS myelination
谷氨酸转运蛋白作为中枢神经系统髓鞘形成的调节剂
- 批准号:
8999028 - 财政年份:2015
- 资助金额:
$ 19.06万 - 项目类别:
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
PD-Ialpha/ATX 在前脑少突胶质细胞规范和迁移中的作用
- 批准号:
7595242 - 财政年份:2008
- 资助金额:
$ 19.06万 - 项目类别:
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
PD-Ialpha/ATX 在前脑少突胶质细胞规范和迁移中的作用
- 批准号:
7429857 - 财政年份:2008
- 资助金额:
$ 19.06万 - 项目类别:
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
PD-Ialpha/ATX 在前脑少突胶质细胞规范和迁移中的作用
- 批准号:
7796807 - 财政年份:2008
- 资助金额:
$ 19.06万 - 项目类别:
Guidance of Oligodendrocyte Processes: The Role of Local Protein Synthesis
少突胶质细胞过程的指导:局部蛋白质合成的作用
- 批准号:
7210043 - 财政年份:2007
- 资助金额:
$ 19.06万 - 项目类别:
Guidance of Oligodendrocyte Processes: The Role of Local Protein Synthesis
少突胶质细胞过程的指导:局部蛋白质合成的作用
- 批准号:
7350909 - 财政年份:2007
- 资助金额:
$ 19.06万 - 项目类别:
Mechanisms in CNS myelination: Role of PD-lalpha/ATX
CNS 髓鞘形成机制:PD-lalpha/ATX 的作用
- 批准号:
9332470 - 财政年份:2004
- 资助金额:
$ 19.06万 - 项目类别:
Central Nervous System myelination: Role of Phosphodiesterase Autotaxin
中枢神经系统髓鞘形成:磷酸二酯酶自分泌运动因子的作用
- 批准号:
7155529 - 财政年份:2004
- 资助金额:
$ 19.06万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.06万 - 项目类别:
Research Grant














{{item.name}}会员




